Washington / Bilbao / Rochester / Wollongong / Adelaide / York / Tokyo / Amsterdam / Dublin / Barcelona / Calgary / London / /
Company
UK. dCochrane Acute Respiratory Infections Group / eEli Lilly & Co. Australia / Quintiles Co. USA. / HTAi Interest Sub Group / Sanofi / HTAi Interest Group / Agency for Drugs / Education Working Group / Agency for Health Information Assessment / Amgen Inc. / Lilly / Danone / Genzyme / HTA / Economics & Social Policy Group / Medco Health Solutions Inc. / Biosource Corporation / GlaxoSmithKline / Agency for Health / Medtronic / Canadian Agency for Drugs / Cochrane Review Group / Interest Sub Group / Panel Session / /
Continent
Asia / Europe / /
Country
Norway / Thailand / Brazil / United Kingdom / Finland / Denmark / Italy / Malaysia / Argentina / Spain / Netherlands / France / Japan / Canada / Australia / Korea / India / Germany / Sweden / Belgium / Austria / United States / South Korea / /
Event
Business Partnership / FDA Phase / Product Issues / /
Facility
University of York / Memorial Sloan Kettering Cancer Center / dMacMaster University / National Institute / Durhane Wong-Riegere University of Glasgow / cKarilonska Institute / bYale University / University of London / Sahlgrenska University Hospital / University Hospital / University of Adelaide / bNational Institute / Hospital Federation / Hospital Based HTA / University of South Australia / fNational Institute / Sandy Oliverc University of Sheffield / dLudwig Boltzmann Institute / Institute of Health Policy / Economic Review Massachusett General Hospital’s Institute / National Institute of Clinical Excellent / McMaster University / cMedco Research Institute / Capacity building / bUniversity College / cRitsumeikan University / dEuropean Hospital / cJohns Hopkins Berman Institute of Bioethics / bBrunel University / Sripen Tantivessd National Institute / University of Erlangen-Nuremberg / Hospital Clínic / University of Buenos Aires / Catholic University / Evaluation Research Unit Mayo Clinic / /
IndustryTerm
genome-based technologies / pharmaceutical highlighting methodological challenges / health technology / approach to devices / health technologies / pharmaceuticals / non drug technologies / catalyzed networking / interventional technologies / Online Learning Environments / collection tools / health care technologies / health technology assessment / healthcare reform / health-care systems / resources/technologies / the rare disease treatment / target patient / formal systems / alert systems / health services / policy network / assessment systems / technology development / rare disease treatment / therapies for rare diseases / healthcare stakeholders / codependent technologies / health systems / therapies for Alzheimer’s Disease / Online teaching/learning / health care technology assessment / co-dependent technologies / potential solutions / healthcare / project management / genome-base technologies / technology decisions / healthcare technologies / health care systems / heath systems / co-dependent health technologies / /
MedicalCondition
Gerd J / diseases / flu / common diseases / influenza / Alzheimer’s Disease / disease / chronic diseases / rare diseases / breast cancer / cancer / acute and chronic diseases / MS / rare disease / /
MedicalTreatment
vaccination / cochlear implants / /
NaturalFeature
Forth Valley / /
Organization
bNational Institute for Health and Clinical Excellence / University of South Australia / World Health Organization / bYale University / eThe Royal Netherlands Academy of Arts / cHealth Department / Australian Government / Center for Medical Technology Policy / Centre of Public Health Excellence / Drug Administration USA / New and Emerging Health Technologies Committee / University of Erlangen-Nuremberg / Department of Medical Consultancy / Norwegian Knowledge Centre for Health Services / Department of Health / University of London / Lizzie Amise International Alliance of Patients / Norwegian Knowledge Centre for the Health Services / HTAi Board / McMaster University / Sahlgrenska University Hospital / Healthcare Products Regulatory Agency / bNational Institute for Health / Centre for Innovation / University Hospital / Basque Office / Interdisciplinary Centre for Health Technology Assessment / dRegional Agency for Health / National Institute of Clinical Excellent / dEuropean Hospital / Mitch Sugarmand HTAi Secretariat / University of Twente / UK Department / Durhane Wong-Riegere University of Glasgow / Clinical and Economic Review Massachusett General Hospital’s Institute for Technology Assessment / Agency for Health and Social Care / Centre for Socioeconomic Research / Jack Spaapene Catalan Agency for Health Information Assessment and Quality / University of Adelaide / Institute of Health Policy / Centre for Health Technology Evaluation / Patient Involvement and Education Working Group of the HTAi Interest Sub-Group on Patient / Institute of Health Economics / Guido Rasig HTAi Secretariat / Catholic University / School of Economics / Clinical Excellence / Institute of Bioethics / HTA Agency / Government of Catalonia / bKnowledge and Evaluation Research Unit / OECD / Medicare / Institute for Clinical Effectiveness and Health Policy / Academy of Arts and Sciences / National Institute for Health and Clinical Excellence / University of Sheffield / MHRA / Health Care Insurance Board / Maastricht University / Healthcare Federation / European Union / EUnetHTA Joint Action / NHS / Federal Joint Committee / eCanadian Agency for Drugs and Technologies / Ministry of Health / bLondon School / Canadian Agency for Drugs and Technologies / cJohns Hopkins Berman Institute / fNational Institute for Health / University of York / Basque Government / University of Buenos Aires / dLudwig Boltzmann Institute for Health Technology Assessment / Guido Costamagnaf HTA Unit / National Institute for Health / Division of Health Sciences / bFinnish Office / School of Public Health / Office for Health Technology Assessment / Memorial Sloan Kettering Cancer Center / Centre for Health Economics and Policy Analysis / General Directorate for Health and Consumer Protection / Health Technology Assessment / Faculty of Economics / Medical Services Advisory Committee / HTA Unit / National Institute for Clinical Excellence / /
Person
Bruce Campbell / Irene Lenoir-Winjkoopa / Roberta Joppid / Albert Wealeb / Murray Rossd / Beate Wieselere / David Veenstrac / Carole Longsonf / Berit Morland / Katrine Frønsdal / Carole Longsonc / Lazar Mathew Thalakkoturd / David Haileyc / Payer / François Meyerf / Silvia Evers / Tara Schullera / Joseph Mathewa / Sari Ormstada / Jan van der Wilt / Clare Parkerb / Laura Sampietro-Colomc / David Graingere / Eric de Roodenbekee / Lieven Annemanse / Aggie Paulus / Carole Longson / Americo Cicchettib / Sun-Hae Lee Robin / Jose Asuac / Tom Noseworthye / Katrine Fronsdal / Roberto Grillid / Peter Littlejohnsa / Finn Boerlum Kristensen / Danica Marinac-Dabice / Chris Henshalld / Jan Hillert Hillert / Franco Sassi / Bjørn Hofmann / Yvonne Bombardb / Sean Tunisb / Andrew Mitchella / Karla Douwa / Karen Faceyc / Sean Tunisa / Denis Bélangerb / Nick Crabbb / Pascale Gareld / Guido Rasig / Mike Kellyb / Carol Lefebvreb / Logan Mardhani-Baynea / Nilay Shahb / Iñaki Gutiérrez-Ibarluzeae / Flávia Tavares Silva Eliasb / Janneke Gruttersa / Maite Solans-Domènecha / Finn Borlum Kristensen / Ruth Fadenc / Peter Lubor Kolominsky-Rabasa / Andres Pichon Rivierec / Jean-Pierre Lehnerg / Jack Spaapene / Lloyd Sansomd / Vinita Mahtani-Chuganib / Gary Cutter / Victoria Wurcele / Franz Pichlerf / Mirella Marlowb / Andrés Pichon-Rivierec / Guido Costamagnaf / Molly Morganb / Elisabeth Paternostrea / Anne Solessf / Martine Eliase / Matthias Perlethd / Carlo Incertig / Brendon Kearneyc / Charles Turkelson / Guy Maddernd / Sean Tunise / Carole Longsond / Aggie Paulusa / Andrew Bootha / Leonie Segal / Alicia Granadosa / Bill Dempsterb / Julia Abelsonc / David Krylc / David Graingerb / Jim Cox-Chapmand / Robyn Wardc Australian / Silvia Eversa / Tom Jeffersond / Mitch Sugarmand / Steven Pearsond / Meindert Boysen / Jean Mossmanb / Nancy Dreyerc / José A. Expositoa / Julie Glanvillec / Karen Faceyf / Gordon Guyattd / Sarah Kleijnen / Elaine MacPhaild / Tanja Krones / Robert Epsteinc / Franco Sassic / Iñaki Gutiérrez-Ibarluzea / Katrine Fronsdalb / Logan Mardhani-Baynef / Paula Adama / Franz Pichler / Mel Walkera / Robert Epsteinb / Chris Henshallg / Lise Rochaixa / Claudia Wild / Andrew Mitchellc / Andrew Cookc / Laura Sampietro-Collomb / Marianne Klempa / Marta Aymerichd / Gabrielle Troncosod / Katrine Frønsdala / Rourkee Pichlerf / Anne Leeb / Takeru Shiroiwac / Chris Henshallb / Tom Jeffersonb / Tammy Clifforde / Carlo Incertie / Hannah Patricka / Claudia Wildd / Takashi Fukudab / Mike Kelly / Ulla Saalasti-Koskinend / Sarah Kleijnenc / Jackie Streeta / Iris Paternackb / Karl Claxtonb / David McDaid / Durhane Wong-Rieger / David McDaidb / Janet Martinc / Leonie Segald / Karen Faceya / Chris Henshall / Marco Marchettia / David Grainger / Jens Grueger / Kelly Gormand / Joan Berezanskid / Chris Henshalle / Patrick Bossuytd / Bruce Campbellb / /
Position
Manager / Assessors and Clinicians Marco Marchettia / Professor / representative / investigator / driver / Minister / dPro-Health Physicians Chief Medical Officer / advocate / manager / clinicians and assessors / researcher / Chair / Chair of Policy / /
Documento descargado de http://www.elsevier.es elCopia para uso personal, se prohíbe la transmisión de este documento por cualquier medio o formato. Gac Sanit. 2012; 26(Espec Congr 2):16-26 9th HTAi ANNUA